rotating globe
14 Oct 2025


WHO Flags Coldrif, Respifresh TR, and ReLife Syrups After Fatalities

Child deaths in Madhya Pradesh prompt WHO to issue a global alert on three Indian cough syrups in which traces of diethylene glycol, a toxic industrial chemical, were found

Health authorities have raised alarm over three cough syrups made in India, following the tragic deaths of several children in Madhya Pradesh. The World Health Organization (WHO) has warned that Coldrif, Respifresh TR, and ReLife contain diethylene glycol, a toxic chemical used in industry, at dangerous levels.

The syrups have been linked to the deaths of young children under five in Chhindwara district, sparking concern across the country. While investigations show these medicines were not exported, the WHO has urged countries to remain vigilant and report any detection of the products, emphasizing the potential global health risk if unregulated exports occur.

Indian authorities have acted quickly to contain the situation. The company producing Coldrif has had its manufacturing license revoked, and its facility has been shut down. Local distributors found storing medicines without proper refrigeration or documentation have faced license cancellations, and enforcement drives are underway to curb illegal sales, especially of medicines meant for children.

Thousands of bottles of banned cough syrups have been seized in multiple states, some lacking proper safety labels or warnings, and unsafe for children under four. Health officials stress that these measures are essential to prevent further tragedies and ensure the safety of young patients.

This incident highlights the vulnerability of children to unsafe medicines and the need for strict quality control across the pharmaceutical supply chain. Parents and caregivers are urged to avoid the flagged syrups and seek immediate medical attention if their children show any signs of illness after consuming cough medicines.

Experts say the tragedy is a stark reminder of the importance of vigilance in both production and distribution of medicines, as even a small lapse can have devastating consequences. The WHO’s warning underscores the urgent need for stronger regulation, enforcement, and awareness to protect the most vulnerable.

Also Read: Two Terrorists Killed in Kupwara, Kashmir LoC Foiled Infiltration